Our Services

Scientific Back-Office

Scientific, medical and regulatory expertise to inform your decision making.

Investing-in and steering life science assets requires to take decisions that are informed by scientific data, medical context, regulatory guidelines and methodological aspects.

Health Economia Advisory team will review existing data, development plans, and provide analyses to inform your decisions.

We support your key decisions such as:

  • Due diligence preparation and execution (sell side or buy side)
  • Endorsement of the compounds’ development strategy
  • Initiation or wind-down of major activities such as clinical trials
To keep it simple: consider Health Economia Advisory team as your Scientific Back-Office.

Drug Development Studio

Let your asset’s team focus on the science, yet secure the performance of enabling activities to reach the next value inflection-point, and beyond.

The most innovative team does not have to learn it all at once. Health Economia Drug Development Studio will chaperon your team to navigate the complexities of drug development.

Through the Drug Development Studio, we aim to:

  • Refine the compound development plan, ensure that relevant inputs are included
  • Refine the milestones and develop a diligent and realistic planning
  • Secure the performance of enabling activities such as Investigator Brochure development, preparation of interactions with key regulatory agencies, and CRO selection.
  • Enable access to seasoned resources. Coordinate their contribution to accelerate and secure the delivery of the development program
  • Chaperone your assets’ team at every step.
Ultimately, we enable your asset to progress towards value generation.